Literature DB >> 7697502

Differentiated intestinal epithelial cell lines as in vitro models for predicting the intestinal absorption of drugs.

P Wils1, A Warnery, V Phung-Ba, D Scherman.   

Abstract

The oral absorption of a compound is a critical factor for the future of the compound as a drug. This absorption is mainly controlled by the passage across the intestinal epithelium. Thus, the prediction of the intestinal absorption by means of an in vitro model may represent a powerful tool for the early selection of molecules during the process of drug development. In the present study, the differentiated human intestinal epithelial cell line HT29-18-C1, was grown on permeable filters in dual chambers. These cells formed tight monolayers that were used to measure in vitro the transepithelial permeability coefficient (Pc) of various molecules. The results were compared with in vivo data of oral absorption. A threshold value of in vitro permeability of 2 x 10(-6) cm/s was found. Molecules having a permeability coefficient higher than this value were absorbed orally more than 80%, while drugs with Pc values lower than 2 x 10(-6) cm/s were poorly absorbed. By mathematical simulation, it was found that this Pc value, when extrapolated to the surface area and volume of the small intestine, corresponds to an absorption of 80% for a compound with a transit time through the small intestine of 5 h. This demonstrates the predictive utility of the threshold value of the permeability coefficient derived from the in vitro model of intestinal epithelium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7697502     DOI: 10.1007/bf00755788

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  7 in total

1.  Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa.

Authors:  A R Hilgers; R A Conradi; P S Burton
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

2.  Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability.

Authors:  I J Hidalgo; T J Raub; R T Borchardt
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

3.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

Authors:  P Artursson; J Karlsson
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

4.  High lipophilicity decreases drug transport across intestinal epithelial cells.

Authors:  P Wils; A Warnery; V Phung-Ba; S Legrain; D Scherman
Journal:  J Pharmacol Exp Ther       Date:  1994-05       Impact factor: 4.030

5.  HT29-18-C1 intestinal cells: a new model for studying the epithelial transport of drugs.

Authors:  P Wils; S Legrain; E Frenois; D Scherman
Journal:  Biochim Biophys Acta       Date:  1993-06-06

6.  Dihydrofolate reductase gene amplification-associated shift of differentiation in methotrexate-adapted HT-29 cells.

Authors:  T Lesuffleur; A Barbat; C Luccioni; J Beaumatin; M Clair; A Kornowski; E Dussaulx; B Dutrillaux; A Zweibaum
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

7.  Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation.

Authors:  C Huet; C Sahuquillo-Merino; E Coudrier; D Louvard
Journal:  J Cell Biol       Date:  1987-07       Impact factor: 10.539

  7 in total
  4 in total

Review 1.  The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications.

Authors:  V Meunier; M Bourrié; Y Berger; G Fabre
Journal:  Cell Biol Toxicol       Date:  1995-08       Impact factor: 6.691

2.  Development of a serum-free co-culture of human intestinal epithelium cell-lines (Caco-2/HT29-5M21).

Authors:  Géraldine Nollevaux; Christelle Devillé; Benaïssa El Moualij; Willy Zorzi; Patricia Deloyer; Yves-Jacques Schneider; Olivier Peulen; Guy Dandrifosse
Journal:  BMC Cell Biol       Date:  2006-05-02       Impact factor: 4.241

3.  The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation.

Authors:  S M D K Ganga Senarathna; Madhu Page-Sharp; Andrew Crowe
Journal:  PLoS One       Date:  2016-04-05       Impact factor: 3.240

4.  Inhibition of EV71 by curcumin in intestinal epithelial cells.

Authors:  Hsing-I Huang; Chi-Chong Chio; Jhao-Yin Lin
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.